NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,822 | +97399.1% | 3,130 | -3.4% | 0.13% | +2.4% |
| Q2 2023 | $327 | +9.7% | 3,241 | 0.0% | 0.12% | +6.0% |
| Q1 2023 | $298 | +1.7% | 3,241 | +0.2% | 0.12% | -1.7% |
| Q4 2022 | $293 | -99.9% | 3,234 | +26.5% | 0.12% | +29.7% |
| Q1 2022 | $224,000 | 0.0% | 2,557 | 0.0% | 0.09% | +7.1% |
| Q4 2021 | $224,000 | -11.5% | 2,557 | -17.5% | 0.08% | -11.5% |
| Q3 2021 | $253,000 | -10.6% | 3,098 | 0.0% | 0.10% | -11.9% |
| Q2 2021 | $283,000 | +10.1% | 3,098 | +3.0% | 0.11% | +0.9% |
| Q1 2021 | $257,000 | -11.1% | 3,008 | -1.7% | 0.11% | -10.7% |
| Q4 2020 | $289,000 | +8.2% | 3,060 | -0.4% | 0.12% | -14.8% |
| Q3 2020 | $267,000 | -2.6% | 3,071 | -2.0% | 0.14% | -41.6% |
| Q2 2020 | $274,000 | – | 3,133 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |